naftopidil and Kidney Neoplasms

naftopidil has been researched along with Kidney Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arima, K; Ishii, K; Iwamoto, Y; Kanda, H; Kato, M; Sasaki, T; Shiraishi, T; Sugimura, Y; Yamada, Y1
Gotoh, A; Kanno, T; Nagaya, H; Nishizaki, T1

Other Studies

2 other study(ies) available for naftopidil and Kidney Neoplasms

ArticleYear
Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:9

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Proliferation; Cells, Cultured; Female; Flow Cytometry; G1 Phase; Human Umbilical Vein Endothelial Cells; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthalenes; Piperazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2013
Antitumor action of α(1)-adrenoceptor blockers on human bladder, prostate and renal cancer cells.
    Pharmacology, 2012, Volume: 90, Issue:5-6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Humans; Kidney Neoplasms; Male; Naphthalenes; Piperazines; Prazosin; Prostatic Neoplasms; Urinary Bladder Neoplasms

2012